Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma.

Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma. Abstract Text:

D E Johnson,R A Chalbaud,P Y Holoye,M L Samuels,

This study had the limited aim of ascertaining the efficacy of bleomycin in controlling m etastatic renal carcinoma. Fifteen patients received bleomycin intramuscularly and five patients received the drug via continuous infusion. Only two patients had responses, both mixed. We concluded that the therapeutic value of bleomycin in the treatment of advanced renal carcinoma is negligible.

Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma. Publishing Authors By Initials

DE Johnson,RA Chalbaud,PY Holoye,ML Samuels,

For similar neoplasms: neoplastic processes: neoplasm metastasis research abstracts see: neoplasms: neoplastic processes: neoplasm metastasis research

PUBMED ID PMID:

MEDLINE DATE: 1975 Mar-Apr

Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer chemotherapy reports. Part 1

VOLUME: 59

Page Numbers: 433-5

Journal Abbreviation:

ISSN: 0069-0112

DAY: 20

MONTH: 02

YEAR: 2008

Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7607105

Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma. Keywords Mesh Terms:

KEYWORDS: Neoplasm Metastasis

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma. Information

Substance Name: Bleomycin

Registry Number: 11056-06-7

Grant and Affiliation Information for Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Chemother Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical trial of bleomycin NSC-125066 in the treatment of metastatic renal carcinoma Related Publications

• Artificial regulation of ospC expression in Borrelia burgdorferi.
• California surveillance for pesticide-related illness and injury: coverage, bias, and limitations.
• Cancer chemotherapeutic response and intravenous hyperalimentaion.
• Characterization of Arabidopsis ABCG11/WBC11, an ATP binding cassette (ABC) transporter that is required for cuticular lipid secretion.
• Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma.
• Clozapine use in a forensic population in a New South Wales prison hospital.
• Combination vincristine (NSC-67574) and hydroxyurea (NSC-32065) for metastatic renal carcinoma.
• Early effects of testosterone propionate on the seminal vesicles of castrate rats.
• Farnesyl pyrophosphate is a novel transcriptional activator for a subset of nuclear hormone receptors.
• Genetics of cholesterol and lipoprotein metabolism.
• Gill Samuels.
• History of safe use as applied to the safety assessment of novel foods and foods derived from genetically modified organisms.
• Industrial accidents and peripheral vascular diseases.
• Influence of previous diet on metabolism during fasting.
• Intrathecal methotrexate (NSC-740) therapy for brain tumors in children.
• Meeting the health needs of rural America--the Kirksville mission.
• Mitochondrial AZT metabolism.
• Necrosis of intraocular tissues.
• Nuclear receptor coregulator (NRC): mapping of the dimerization domain, activation of p53 and STAT-2, and identification of the activation domain AD2 necessary for nuclear receptor signaling.
• PARTICIPATION OF THE OCULAR APPENDAGES IN SYMPATHETIC OPHTHALMIA AND ITS BEARING ON ENUCLEATION.
• Psychiatrists' ascertained treatment needs for mental disorders in a population-based sample.
• Role of PSF-TFE3 oncoprotein in the development of papillary renal cell carcinomas.
• SPECTROFLUORIMETRIC MEASUREMENT OF 1,3-DIAMINO-5-METHYLPHENAZINIUM CHLORIDE (NSC-33419) IN URINE.
• Selection against Pathogenic mtDNA Mutations in a Stem Cell Population Leads to the Loss of the 3243A-->G Mutation in Blood.
• Sleep, recovery, and performance: the new frontier in high-performance athletics.
• Temperature-induced regulation of RpoS by a small RNA in Borrelia burgdorferi.
• The application of post-market monitoring to novel foods.
• The effects of promazine on psychiatric symptoms.
• Thiopropazate hydrochloride (dartal) chemotherapy for emotional disorders; a clinical evaluation.
• Varieties of dual-process theory for probabilistic reasoning.